Sona Nanotech Inc. (CSE:SONA)
Canada
· Delayed Price · Currency is CAD 0.360
-0.040 (-10.00%)
Mar 9, 2026, 3:21 PM EST
Sona Nanotech Company Description
Sona Nanotech Inc. operates as a nanotechnology life sciences company in the United States and Canada The company researchers and develops gold nanoparticles for potential therapies, including photothermal therapy, tumor targeting activity, anti-bacterial activity, and drug delivery vehicle, as well as diagnostics, such as diagnostic markers for imaging and immunoassay and biosensing.
It also engages in the development of targeted hyperthermia therapy, a photo thermal therapy for the treatment of cancer tumors; and diagnostic tools comprising lateral flow assay rapid and bovine tuberculosis tests.
The company was founded in 2013 and is based in Halifax, Canada.
Sona Nanotech Inc.
| Country | Canada |
| Founded | 2013 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| CEO | David Regan |
Contact Details
Address: Purdy’s Wharf Tower II Halifax, NS B3J 3R7 Canada | |
| Phone | 902-442-0653 |
| Website | sonanano.com |
Stock Details
| Ticker Symbol | SONA |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | November - October |
| Reporting Currency | CAD |
| ISIN Number | CA83541C1059 |
| SIC Code | 1000 |
Key Executives
| Name | Position |
|---|---|
| David Andrew Regan | Chief Executive Officer |
| Robert William George Randall CPA | Chief Financial Officer and Corporate Secretary |
| Dr. Len Pagliaro Ph.D. | CSO and Director |
| Dr. Carman Giacomantonio M.D., M.Sc. | Chief Medical Officer |
| Dr. Kulbir Singh Ph.D. | Co-Founder and Head of Research & Development |
| Dr. Mike McAlduff | Director of Research & Development and Production and Founder |
| Dr. Gerrard Marangoni | Co-Founder and Member of Scientific Advisory Board |
| Darren Rowles | Head of Diagnostics |